Tower Research Capital LLC (Trc) Axogen, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Axogen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,385 shares of AXGN stock, worth $58,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,385
Previous 8,055
57.98%
Holding current value
$58,188
Previous $58,000
18.97%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AXGN
# of Institutions
162Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$70.3 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$55.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$51.7 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$49.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$41.7 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $727M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...